Risk factor
High price volatility
Profitability factor
Greatly overvalued vs peers
About
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, overpriced on P/FC
Target Price
The average target price of HNGE is 70 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug